Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters

Intracerebral transplantation of dopaminergic (DA) cells is currently further explored as a potential restorative therapy for Parkinson's disease (PD). However, before they can be considered for a more widespread clinical use a number of critical issues have to be resolved, including an optimiz...

Full description

Bibliographic Details
Main Authors: Guido Nikkhah M.D., Ph.D., Christoph Rosenthal, Gero Falkenstein, Alexandra Roedter, Anna Papazoglou, Almuth Brandis
Format: Article
Language:English
Published: SAGE Publishing 2009-02-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368909788341324
id doaj-68e70cfa7f684c7fabcb1c0a57b2d754
record_format Article
spelling doaj-68e70cfa7f684c7fabcb1c0a57b2d7542020-11-25T03:03:21ZengSAGE PublishingCell Transplantation0963-68971555-38922009-02-011810.3727/096368909788341324Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting ParametersGuido Nikkhah M.D., Ph.D.0Christoph Rosenthal1Gero Falkenstein2Alexandra Roedter3Anna Papazoglou4Almuth Brandis5Department of Stereotactic and Functional Neurosurgery, Laboratory of Molecular Neurosurgery, Neurocenter, Albert-Ludwigs-University, Freiburg, GermanyDepartment of Stereotactic and Functional Neurosurgery, Laboratory of Molecular Neurosurgery, Neurocenter, Albert-Ludwigs-University, Freiburg, GermanyDepartment of Stereotactic and Functional Neurosurgery, Laboratory of Molecular Neurosurgery, Neurocenter, Albert-Ludwigs-University, Freiburg, GermanyDepartment of Stereotactic and Functional Neurosurgery, Laboratory of Molecular Neurosurgery, Neurocenter, Albert-Ludwigs-University, Freiburg, GermanyDepartment of Stereotactic and Functional Neurosurgery, Laboratory of Molecular Neurosurgery, Neurocenter, Albert-Ludwigs-University, Freiburg, GermanyInstitute of Neuropathology, Medical School Hanover, Hanover, GermanyIntracerebral transplantation of dopaminergic (DA) cells is currently further explored as a potential restorative therapy for Parkinson's disease (PD). However, before they can be considered for a more widespread clinical use a number of critical issues have to be resolved, including an optimized transplantation protocol. This study has been performed in a rat 6-hydroxydopamine model of PD and is based on the microtransplantation approach. The results demonstrate a reduced survival (threefold) for a single cell suspension of E14 rat ventral mesencephalon compared to a fragment suspension when a metal cannula is used for implantation. However, fragment suspensions result in a more variable graft survival and ectopically placed cells along the implantation tract. When a glass capillary is used for implantation, the survival of the single cell suspension (so-called “micrograft”) improved by fourfold (vs. single cells/metal cannula) and is superior to the combination of the metal cannula and fragment suspension (+40%). The micrografts show a reduced variability in DA neuron survival as well as fewer ectopically placed cells. Moreover, the implantation time can significantly be reduced from 19 to 7 min in micrografted animals without a compromise in DA graft survival and functional behavioral outcome. Using the microtransplantation approach graft size can be tailored effectively by varying the density of the final cell suspension at least between 11,000 and 320,000 cells/μl, resulting in comparable survival of tyrosine hydroxylase (TH)-positive neurons in the range of 2–4%. With this approach no more than 100 surviving TH-positive neurons are necessary to produce functional effects in the amphetamine-induced rotation test. Interestingly, we found that DA micrografts into lesion striatum present 20% higher survival rates of TH neurons in comparison to the intact striatum. In summary, these results provide further evidence for the usefulness of the microtransplantation approach and allow for a more precise and tailored adaptation of the implantation parameters for further studies on DA, and possibly also other neural-, glial-, and stem cell-derived grafts.https://doi.org/10.3727/096368909788341324
collection DOAJ
language English
format Article
sources DOAJ
author Guido Nikkhah M.D., Ph.D.
Christoph Rosenthal
Gero Falkenstein
Alexandra Roedter
Anna Papazoglou
Almuth Brandis
spellingShingle Guido Nikkhah M.D., Ph.D.
Christoph Rosenthal
Gero Falkenstein
Alexandra Roedter
Anna Papazoglou
Almuth Brandis
Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters
Cell Transplantation
author_facet Guido Nikkhah M.D., Ph.D.
Christoph Rosenthal
Gero Falkenstein
Alexandra Roedter
Anna Papazoglou
Almuth Brandis
author_sort Guido Nikkhah M.D., Ph.D.
title Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters
title_short Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters
title_full Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters
title_fullStr Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters
title_full_unstemmed Microtransplantation of Dopaminergic Cell Suspensions: Further Characterization and Optimization of Grafting Parameters
title_sort microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2009-02-01
description Intracerebral transplantation of dopaminergic (DA) cells is currently further explored as a potential restorative therapy for Parkinson's disease (PD). However, before they can be considered for a more widespread clinical use a number of critical issues have to be resolved, including an optimized transplantation protocol. This study has been performed in a rat 6-hydroxydopamine model of PD and is based on the microtransplantation approach. The results demonstrate a reduced survival (threefold) for a single cell suspension of E14 rat ventral mesencephalon compared to a fragment suspension when a metal cannula is used for implantation. However, fragment suspensions result in a more variable graft survival and ectopically placed cells along the implantation tract. When a glass capillary is used for implantation, the survival of the single cell suspension (so-called “micrograft”) improved by fourfold (vs. single cells/metal cannula) and is superior to the combination of the metal cannula and fragment suspension (+40%). The micrografts show a reduced variability in DA neuron survival as well as fewer ectopically placed cells. Moreover, the implantation time can significantly be reduced from 19 to 7 min in micrografted animals without a compromise in DA graft survival and functional behavioral outcome. Using the microtransplantation approach graft size can be tailored effectively by varying the density of the final cell suspension at least between 11,000 and 320,000 cells/μl, resulting in comparable survival of tyrosine hydroxylase (TH)-positive neurons in the range of 2–4%. With this approach no more than 100 surviving TH-positive neurons are necessary to produce functional effects in the amphetamine-induced rotation test. Interestingly, we found that DA micrografts into lesion striatum present 20% higher survival rates of TH neurons in comparison to the intact striatum. In summary, these results provide further evidence for the usefulness of the microtransplantation approach and allow for a more precise and tailored adaptation of the implantation parameters for further studies on DA, and possibly also other neural-, glial-, and stem cell-derived grafts.
url https://doi.org/10.3727/096368909788341324
work_keys_str_mv AT guidonikkhahmdphd microtransplantationofdopaminergiccellsuspensionsfurthercharacterizationandoptimizationofgraftingparameters
AT christophrosenthal microtransplantationofdopaminergiccellsuspensionsfurthercharacterizationandoptimizationofgraftingparameters
AT gerofalkenstein microtransplantationofdopaminergiccellsuspensionsfurthercharacterizationandoptimizationofgraftingparameters
AT alexandraroedter microtransplantationofdopaminergiccellsuspensionsfurthercharacterizationandoptimizationofgraftingparameters
AT annapapazoglou microtransplantationofdopaminergiccellsuspensionsfurthercharacterizationandoptimizationofgraftingparameters
AT almuthbrandis microtransplantationofdopaminergiccellsuspensionsfurthercharacterizationandoptimizationofgraftingparameters
_version_ 1724686188690800640